摘要
Background: To develop a serum-specific protein fingerprint which is capable of differentiating samples from patients with pancreatic cancer and those with other pancreatic conditions. Methods: We used SELDI-TOF-MS coupled with CM10 chips and bioinformatics tools to analyze a total of 118 serum samples in this study; 78 serum samples were analyzed to establish the diagnostic models and the other 40 samples were analyzed on the second day as an independent test set. Results: The analysis of this independent test set yielded a specificity of 91.6% and a sensitivity of 91.6% for pattern 1, which distinguished pancreatic adenocarcinoma (PC) from healthy individuals and a specificity of 80.0% and a sensitivity of 90.9% for pattern 2, which distinguished PC from chronic pancreatitis. Conclusion: This study indicated that the SELDI-TOF-MS technique can facilitate the discovery of better serum tumor biomarkers and a combination of specific models is more accurate than a single model in diagnosis of PC.
学科与关键词
- Enhanced Detection of Early Hepatocellular Carcinoma by Serum SELDI-TOF Proteomic Signature Combined with Alpha-Fetoprotein MarkerChen, Lei*; Ho, David W. Y.; Lee, Nikki P. Y.; Sun, Stella; Lam, Brian; Wong, Kwong-Fai; Yi, Xin; Lau, George K.; Ng, Eddy W. Y.; Poon, Terence C. W.; Lai, Paul B. S.; Cai, Zongwei; Peng, Jirun; Leng, Xisheng; Poon, Ronnie T. P.; Luk, John M.Annals of Surgical Oncology, 2010, 17(9): 2518-2525.被引 37
- SELDI蛋白质芯片技术在肝癌中的应用农世泽; 黄承乐; 梁林慧; 冯国钢; 王献民检验医学与临床, 2013, (10): 1276-1278.
- Advances in biomarkers and techniques for pancreatic cancer diagnosisWu, Haotian; Ou, Suwen; Zhang, Hongli; Huang, Rui; Yu, Shan*; Zhao, Ming*; Tai, Sheng*Cancer Cell International, 2022, 22(1): 220.被引 13
